Agoracom Blog Home

Posts Tagged ‘small cap’

DATAMETREX $DM.ca IDENTIFIES CHINESE CAMPAIGNS TO MANIPULATE SOCIAL MEDIA SURROUNDING #COVID19

Posted by AGORACOM-JC at 7:29 AM on Wednesday, April 1st, 2020
  • Work done for the United States Government clearly identifies attempts by Chinese authorities to create a divide amongst Americans on how the administration and Trump are handling #COVID19
  • Report can be viewed here: http://datametrex.com/investor/covid19-report.html

TORONTO, April 01, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to share a summary of the work done for the United States Government and a link to the report which clearly identifies attempts by Chinese authorities to create a divide amongst Americans on how the administration and Trump are handling #COVID19. This work was commissioned by an agency for the United States Government and involved collecting and analyzing a massive amount of social media data.  

Datametrex examined millions of social media documents over the last month tracking Chinese involvement in the online discussions surrounding the COVID-19 and coronavirus. Datametrex found significant attempts by both Chinese authorities and news agencies to manipulate the media and shift the blame for the COVID-19 outbreak to the United States. Additional attempts at media manipulation and narrative shaping included attempts to frame dialogue from US President Trump as racist and show the Trump administration as an impediment to the worldwide recovery from the pandemic while framing Chinese President Xi as a strong leader on the world stage.

“We are thrilled to be working with the US Government on this very serious topic, this report goes to show that social media warfare goes beyond attempts to tamper with elections as we clearly identified during the Canadian Federal Elections. The Company is open for business in the US and we look forward to working with more government agencies and corporate clients on disinformation, propaganda, fake news in social media,” says Marshall Gunter, CEO of the Company

Please click the link below to view the report:

http://datametrex.com/investor/covid19-report.html

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Empower Clinics $CBDT.ca Announces March 2020 Patient Growth Of 593% and 1Q 2020 Visits Increasing By 478% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:21 AM on Wednesday, April 1st, 2020
  • Announced that patient visits in corporate clinics increased by 593%% in March 2020 versus the same period in 2019,
  • total patient visits of 2,160 in March 2020 compared to 364 in March 2019
  • 1Q 2020 patient visits increased by 478% versus the same period 2019, with total patient visits of 5,717 in 1Q 2020 compared to 1,196 in 1Q 2019.

VANCOUVER, BC / April 1, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company, is pleased to announce that patient visits in corporate clinics increased by 593%% in March 2020 versus the same period in 2019, with total patient visits of 2,160 in March 2020 compared to 364 in March 2019.

1Q 2020 patient visits increased by 478% versus the same period 2019, with total patient visits of 5,717 in 1Q 2020 compared to 1,196 in 1Q 2019.

“These are unprecedented times, yet our team members remain dedicated to supporting patients every day, at record levels, using new operational techniques and safety protocols” said Steven McAuley, Chairman & CEO of Empower. “I am so proud of our management, our staff’s willingness to adjust to changing times, and our commitment to the daily needs of patients.”

The Company has also entered into to a new tele-medicine service agreement that will provide access to our physicians across multiple states, offering current and new modalities to existing and new patients. Additional announcements about the Company’s digital health initiatives will be forthcoming.

The Company has also issued a total of 600,000 stock options priced at $0.05 CAD to investor relation service providers and to a Director of the Company.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:Steven McAuley

CEO

[email protected]

604-789-2146

Investors:

Dustin Klein
SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Datametrex $DM.ca Working With US Government Agencies on #Covid19 and #Coronavirus Fake News and Disinformation

Posted by AGORACOM-JC at 1:52 PM on Monday, March 30th, 2020
  • Currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19
  • First contract with clients is a pilot for $25,000 USD
  • It was signed on March 12th, 2020 and has a duration of one month

TORONTO, March 30, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to share that Company is currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19. We will provide greater detail on the work we are doing once it is completed and our clients approve it for public dissemination. 

The Company wishes to provide further details to this release as requested by IIROC. This first contract with our clients is a pilot for $25,000 USD. It was signed on March 12th, 2020 and has a duration of one month. The clients contacted Datametrex after witnessing the technology at a NATO working group presentation highlighting Nexalogy’s work on #fakenews and #disinformation in the Canadian Federal Elections. This Pilot represents a major milestone for the Company as it is the natural progression to potentially expand into the US market, specifically the US Government.  

“We are thrilled to be working with the US Government on this very important issue. We recently completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #Coronavirus and secured a relationship with Carnegie Mellon University IDeaS. Both announcements assisted in getting Nexalogy in front of the Government Agencies for this current opportunity in the United States. The solid foundation we have built over the past years with our Canadian Government clients like  DRDC, the Canadian Military and NATO have positioned Datametrex to be able to provide military grade solutions for todays social media challenges”, says Marshall Gunter CEO of Datametrex AI.

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

DATAMETREX #DM.ca WORKING WITH US GOVERNMENT AGENCIES ON #COVID19 AND #CORONAVIRUS

Posted by AGORACOM-JC at 7:23 AM on Monday, March 30th, 2020
  • Company is currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19
  • “We are thrilled to be working with the US Government on this very important issue. We recently completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS…”

TORONTO, March 30, 2020  — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to share that the Company is currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19. We will provide greater detail on the work we are doing once it is completed and our clients approve it for public dissemination. 

“We are thrilled to be working with the US Government on this very important issue. We recently completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS. Both announcements assisted in getting Nexalogy in front of the Government Agencies for this current opportunity in the United States. The solid foundation we have built over the past years with our Canadian Government clients like  DRDC, the Canadian Military and NATO have positioned Datametrex to be able to provide military grade solutions for todays social media challenges”, says Marshall Gunter CEO of Datametrex AI.

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

#Covid19 fake news hacks its way onto government blockchain website – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 12:45 PM on Friday, March 27th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company announced three $1M contacts in Q3-2019. Click here for more info.

Covid-19 fake news hacks its way onto government blockchain website

By: Mariana López

  • On March 14, the government in Argentina disclosed that its system had effectively been hacked.
  • Perpetrator(s) uploaded false information regarding guidelines for public officials on handling the coronavirus (Covid-19) onto the country’s official bulletin website, which just so happens to use blockchain technology. 

As a result, officials took the site temporarily offline.

Correspondingly, another issuance will be necessary to disclaim the false statements posted on its 34,239 editions.

Have the blockchain gods forsaken the government of Buenos Aires? Not exactly. Blockchain isn’t bullet-proof.

Hacked! Why Argentina’s case is a big deal

Perhaps you’re wondering, “what’s the big deal? It’s just a bulletin.”

No, it’s not just a bulletin. 

Many countries have their own official bulletin or gazette wherein laws, notifications, or other big-deal, high-level government information is formally announced.

In Argentina, it’s known as the Boletín Oficial. Mexico’s is christiend the Diario Oficial de la Federación. In the US it’s called the Federal Register.

And the fact that something of such substantial importance in government communications was hacked is both alarming and interesting.

First off, blockchain-based systems are often hailed as more fool-proof to this type of manipulation. 

And that’s because each block within the chain is supposed to have its own unique cryptographic fingerprint and use what’s known as a “consensus protocol.” Through this protocol, the nodes on the network share and record transactional history. 

Thanks to these mechanisms, in theory, not just any outsider can show up and manipulate the data.

But with some creativity and determination, hackers can bust through blockchain’s apparently impenetrable defenses.

Secondly, everyone is well aware of how fake news can make its way onto social media. As a result, we’re consistently advised to only rely on official sources, like government websites, for more information on the pandemic. 

The hacking of a government outlet like Buenos Aires’ means that no source is 100 percent safe and fool-proof to being used as a platform to broadcast false statements.

That’s why we should make an effort to consult additional sources for more information. Especially for a topic as sensitive as healthcare.

And remember, if the government is hackable, so are you. So take the necessary precautions to protect your own data and systems.

Source: https://www.contxto.com/en/argentina/argentina-government-hacked-spread-fake-news/

INTERVIEW: Empower $CBDT.ca #CBD Clinics Designated Essential Service – February Visits Climb 800% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:12 PM on Thursday, March 19th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 351% in Q4 and 800% in February.  But would Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower has had to actually increase operating hours.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history.  

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

Empower Clinics $CBDT.ca Daily Patient Count Continues at Record Pace with Medical Cannabis Certifications Deemed an Essential Service $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:24 AM on Thursday, March 19th, 2020

Empower Clinics adapts operational processes to manage continued record patient counts during COVID-19 outbreak

  • Patient visits in corporate clinics continue at record pace, with patients demonstrating an even greater need for plant-based medicine, as the impact of COVID-19 becomes more pervasive
  • State’s of Arizona and Oregon have declared a State of Emergency over the novel coronavirus outbreak therefore, as a medical service provider, Empowers corporate medical clinics are considered an essential service and are not subject to certain mandated closures

VANCOUVER, BC / March 18, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company, announces that patient visits in corporate clinics continue at record pace, with patients demonstrating an even greater need for plant-based medicine, as the impact of COVID-19 becomes more pervasive.

“The coronavirus crisis is impacting all aspects of our lives, but our clinics remain incredibly busy, as patients show how important their medical cannabis treatment options are to manage increased levels of anxiety, stress, chronic pain and PTSD” said Steven McAuley, Chairman & CEO of Empower. “We had to quickly adapt clinic operating procedures to ensure optimum safety for employees and patients, updated cleaning and sanitation protocols, and provided extensive new communications to our team and patients.”

The State’s of Arizona and Oregon have declared a State of Emergency over the novel coronavirus outbreak therefore, as a medical service provider, Empowers corporate medical clinics are considered an essential service and are not subject to certain mandated closures.

The Company has made changes to clinic operations and patient management based on the most recent recommendations from the (CDC) Centers for Disease Control and Prevention, and their guidance for healthcare facilities.

https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/guidance-hcf.html
https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/index.html

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Empower Clinics $CBDT.ca – #Marijuana Survey Shows #Boomers Embracing #Cannabis & #CBD According to Aging Expert, Lisa Cini $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 6:15 PM on Monday, March 16th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

Marijuana Survey Shows Boomers Embracing Cannabis & CBD According to Aging Expert, Lisa Cini

COLUMBUS, Ohio -With 9 in 10 Americans favoring legalization of Marijuana for recreation or medicinal purposes and New York weeks away from a decision, aging expert Lisa Cini shares details of marijuana and cannabidiol (CBD) usage among the 11,000+ boomers who responded to her marijuana survey and answered a variety of questions on marijuana consumption, opinion, and usage.

“It’s time to mainstream senior-friendly tools for using marijuana, and consider implications for designing seniors’ living spaces, or help those marijuana-using seniors living in multi-generational homes to partake in designated ways and areas as not to offend family members who don’t use, including children and grandchildren.”Tweet this

“I’m not surprised that 83% of the respondents are using some form of cannabis for recreational and medical reasons. 66% partake daily and believe that marijuana and/or CBD use is an important component of their lives,” says Lisa Cini, senior living expert and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive. “Don’t forget that much of the boomer generation grew up smoking weed. Some never stopped, resumed in retirement, or when they were no longer raising children. Because the aging process is unforgiving as it relates to pain, seniors are finding relief from achy bones and joints, arthritis, sleeplessness, and many other ailments, proving that there’s a great deal more to marijuana than just getting high, especially for those battling health and comfort challenges.”

Seniors are using weed in any number of ways, from smoking to baking and preparing full meals with cannabutter for many perceived health benefits including relief from insomnia, anxiety, chronic pain, depression, muscle tension, arthritis, and migraines in addition to getting high.

For those who desire CBD without THC, popular brands like vitafusion™ now offer gummy vitamins with full spectrum hemp extract and natural phytocannabinoids (225mg & 10mg CBD per gummy), Blissful Sleep with 5mg Melatonin (300mg with 10mg CBD per gummy) to induce sleep, and Chillaxed Mood with natural phytocannabinoids & 10mg L-Theanine (300 mg & 10mg CBD per gummy) to promote calm mental alertness, in contrast to the restless energy sometimes produced by caffeine. CBD creams and other skin care products are touted for anti-aging and appeal to boomers. CBD Anti-Aging Cream with Apple Stem Cells, was voted #1 Best Anti-Aging CBD Skin Cream in 2019 and for those with sensitive skin, Abinoid Botanicals Face Serum – Blue Chamomile & Hemp was voted #2 best hemp cream.

“Marijuana and CBD use is a reality that can no longer be ignored, as it’s very much a part of the daily lives of so many,” adds Cini. “It’s time to mainstream senior-friendly tools for using marijuana, and consider implications for designing seniors’ living spaces, or help those marijuana-using seniors living in multi-generational homes to partake in designated ways and areas as not to offend family members who don’t use, including children and grandchildren.”

Lisa Cini is an award-winning senior living designer, President / CEO, Mosaic Design Studio and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive, The Future is Here: Senior Living Re-imagined, and Hive, which describes her family’s four generations living under the same roof in her own home. Go to Lisamcini.com to sign up for her blog. If you want to find the best tech products that help seniors Embrace Aging and Live Independently, visit BestLivingTech.com.

Source: https://www.businesswire.com/news/home/20200309005150/en/Marijuana-Survey-Shows-Boomers-Embracing-Cannabis-CBD

Empower Clinics $CBDT.ca – #Cannabis Won’t Cure #Coronavirus, but It Can Help Ease Certain Flu Symptoms $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:00 PM on Friday, March 13th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

Cannabis Won’t Cure Coronavirus, but It Can Help Ease Certain Flu Symptoms

By Brianna Wheeler |

During a normal flu season, frequent weed smokers know the drill.

Pay closer attention to everyone’s cough patterns during a smoke sesh. Stop accepting mouth-wet blunts from strangers. And if you think you’re coming down with something, wave a lighter under the mouthpiece before passing the pipe.

This year, obviously, things are a bit more serious. We’re dealing with multiple citywide quarantines, global economic disruption, and a pandemic being compared to the damn Spanish flu. It’s enough to make self-respecting cannabis enthusiasts re-evaluate their medicine cabinet and diversify their stash box.

Obviously, there’s no dependable research on CBD’s or THC’s effect on COVID-19. But we do know a few things about cannabis and general wellness. Down the rabbit hole of alternative cannabinoids and non-psychoactive cannabis, there is a wealth of potential medicinal benefits both preventative and curative.

At least when it comes to the regular flu, CBD has been found to help support immune systems, ease symptoms, and replace over-the-counter pain relievers, sleep aids, and medicated salves currently taking up space in our medicine cabinet. But not just any CBD will do, and CBD alone won’t do it all.

Obviously, the best course of action right now is to keep vigorously washing your hands, mind your coughs, avoid large crowds, and be a bit more stingy with your pipes and joints. But if you find yourself slipping under the weather, for whatever reason, here are a few things to know about how cannabis might help ease symptoms.

CBD for Immune System Support

Tons more research is required to accurately map the relationship between the immune and endocannabinoid systems, but it’s well established that CBD helps reduce self-harming autoimmune and inflammatory responses. “CBD has been found to act as an immune system modulator,” says Anna Symonds, director of East Fork Cultivars’ CBD Certified program. “This means that it’s like a thermostat—it can turn the level of activity down or up, depending on the body’s needs.”

Source: https://www.wweek.com/potlander/2020/03/10/cannabis-wont-cure-coronavirus-but-it-can-help-ease-certain-flu-symptoms/

Empower Clinics $CBDT.ca Announces Advancement of Joint Venture with Heritage Cannabis in the United States $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 8:24 AM on Thursday, March 5th, 2020
  • Announced the advancement of its previously announced Joint Venture Partnership with Heritage Cannabis Holdings Corp. (CSE: CANN), based in Sandy, Oregon, USA.
  • Now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon,
  • Will immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States

VANCOUVER, BC / March 5, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company is pleased to announce the advancement of its previously announced Joint Venture Partnership (“JV”) with Heritage Cannabis Holdings Corp. (CSE: CANN) (“Heritage”), based in Sandy, Oregon, USA.

In September 2019, Empower announced it had entered into a Letter of Intent (“LOI”) to form a 50/50 ownership JV with Heritage for the extraction of hemp for CBD oil production, and formulated CBD products. The JV is equally funded by both parties and since formation CDN$250,000 has been provided to the JV.

Heritage and Empower are now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon, in order to immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States.

The proprietary branded products will be distributed through Empower’s corporately owned physician staffed health clinics in Oregon and Arizona, online at www.sunvalleyhealth.com and in upcoming new franchise locations, which currently have access to over 165,000 patients.

Additionally, related downstream equipment is now being installed including gel cap processing, tincture bottle and vape cartridge filling, as well as labelling, packaging, storage and shipping services, to offer full-service end-to-end products to third parties.

Heritage is providing training and supervision related to the proprietary methods of extraction and oil production that is already being successfully produced in Canada by Heritage.

“Having the backing of an experienced partner with the financial strength of Heritage Cannabis is proving to be so beneficial for the development of our first extraction facility”, said Steven McAuley, Chief Executive Officer of Empower. “Together, we have already identified numerous opportunities to bring new orders to the JV facility, ensuring we leverage the capacity we are building.”

“We are very pleased to be advancing our U.S. strategy through this mutually beneficial partnership with Empower, which provides Heritage ease of access to the world’s largest cannabis market”, stated Clint Sharples, Chief Executive Officer of Heritage. “The installation of extraction units is the next phase of the JV and another step toward successfully furthering our growth strategies.”

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

About Heritage Cannabis Holdings Corp.

The Company is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.